Penumbra, Inc. (NYSE:PEN) EVP Johanna Roberts Sells 900 Shares

Penumbra, Inc. (NYSE:PEN) EVP Johanna Roberts sold 900 shares of the business’s stock in a transaction that occurred on Monday, May 12th. The stock was sold at an average price of $298.55, for a total value of $268,695.00. Following the transaction, the executive vice president now directly owns 65,314 shares in the company, valued at approximately $19,499,494.70. This trade represents a 1.36% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink.

Johanna Roberts also recently made the following trade(s):

• On Thursday, April 24th, Johanna Roberts sold 600 shares of Penumbra stock. The stock was sold at an average price of $300.01, for a total value of $180,006.00.
• On Tuesday, April 1st, Johanna Roberts sold 600 shares of Penumbra stock. The shares were sold at an average price of $269.11, for a total value of $161,466.00.
• On Monday, March 3rd, Johanna Roberts sold 600 shares of Penumbra stock. The shares were sold at an average price of $287.43, for a total transaction of $172,458.00.

Penumbra Trading Down 4.5%

NYSE PEN opened at $275.95 on Friday. Penumbra, Inc. has a twelve month low of $148.00 and a twelve month high of $310.00. The business’s fifty day moving average is $279.00 and its 200 day moving average is $262.86. The company has a quick ratio of 3.25, a current ratio of 6.01 and a debt-to-equity ratio of 0.02. The company has a market cap of $10.69 billion, a price-to-earnings ratio of 811.62, a price-to-earnings-growth ratio of 2.83 and a beta of 0.53.

Penumbra (NYSE:PEN) last announced its earnings results on Wednesday, April 23rd. The company reported $0.83 EPS for the quarter, topping the consensus estimate of $0.66 by $0.17. The firm had revenue of $324.14 million for the quarter, compared to the consensus estimate of $315.72 million. Penumbra had a return on equity of 9.74% and a net margin of 1.17%. The business’s quarterly revenue was up 16.3% compared to the same quarter last year. During the same period in the previous year, the business earned $0.41 EPS. As a group, sell-side analysts expect that Penumbra, Inc. will post 3.67 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

Several analysts recently commented on PEN shares. Stifel Nicolaus set a $318.00 target price on shares of Penumbra and gave the stock a “buy” rating in a report on Thursday, April 24th. Robert W. Baird upped their price objective on Penumbra from $316.00 to $325.00 and gave the company an “outperform” rating in a report on Thursday, April 24th. JPMorgan Chase & Co. raised their price target on shares of Penumbra from $230.00 to $285.00 and gave the stock an “overweight” rating in a research report on Wednesday, February 19th. Bank of America began coverage on shares of Penumbra in a research report on Friday, March 14th. They set a “buy” rating and a $320.00 target price on the stock. Finally, Morgan Stanley boosted their price target on Penumbra from $240.00 to $260.00 and gave the company an “equal weight” rating in a research note on Wednesday, February 19th. Three research analysts have rated the stock with a hold rating, fourteen have issued a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $302.40.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently made changes to their positions in the business. Barclays PLC boosted its holdings in shares of Penumbra by 16.5% during the 3rd quarter. Barclays PLC now owns 18,025 shares of the company’s stock worth $3,502,000 after buying an additional 2,559 shares in the last quarter. Pallas Capital Advisors LLC boosted its stake in Penumbra by 3.8% during the fourth quarter. Pallas Capital Advisors LLC now owns 1,108 shares of the company’s stock worth $263,000 after acquiring an additional 41 shares in the last quarter. Park Avenue Securities LLC grew its holdings in Penumbra by 18.6% in the fourth quarter. Park Avenue Securities LLC now owns 1,665 shares of the company’s stock worth $395,000 after purchasing an additional 261 shares during the period. Diversify Wealth Management LLC increased its stake in Penumbra by 36.3% in the fourth quarter. Diversify Wealth Management LLC now owns 1,645 shares of the company’s stock valued at $412,000 after purchasing an additional 438 shares in the last quarter. Finally, UMB Bank n.a. raised its holdings in shares of Penumbra by 57.4% during the fourth quarter. UMB Bank n.a. now owns 192 shares of the company’s stock valued at $46,000 after purchasing an additional 70 shares during the period. 88.88% of the stock is owned by institutional investors and hedge funds.

About Penumbra

Penumbra, Inc, together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers peripheral products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT RX.